Perrigo Company PLC

Common Name

Perrigo

Country

Ireland

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

8,379

Ticker

PRGO

Exchange

NEW YORK STOCK EXCHANGE, INC.

Website

www.perrigo.com

Description

Perrigo Company plc is a leading global provider in the pharmaceutical industry, primarily focused on manufacturing and distributing over-the-counter (OTC) consumer healthcare products. As a prominent... Show more

Income Statement Balance Sheet

Financial Statements of Perrigo

Below are the financial statements of Perrigo, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of USD	2024 as of 2024-12-31	2023 as of 2023-12-31
Assets	—	—
Cash, cash equivalents and restricted cash	558.8^a	751.3^a
Accounts receivable, net	642.3^a	739.6^a
Inventories	1,081.8^a	1,140.9^a
Prepaid expenses and other current assets	199^a	201.1^a
Total current assets	2,481.9^a	2,832.9^a
Property, plant and equipment, net	917.8^a	916.4^a
Operating lease assets	175.2^a	183.6^a
Goodwill and indefinite-lived intangible assets	3,325.4^a	3,534.4^a
Definite-lived intangible assets, net	2,423.7^a	2,980.8^a
Deferred income taxes	5.1^a	25.8^a
Other non-current assets	318.6^a	335.2^a
Total non-current assets	7,165.8^a	7,976.2^a
Total assets	9,647.7^a	10,809.1^a
Liabilities and shareholders’ equity	—	—
Accounts payable	495.2^a	477.7^a
Payroll and related taxes	123.2^a	127^a
Accrued customer programs	133.3^a	163.5^a
Other accrued liabilities	238.7^a	335.4^a
Accrued income taxes	17.4^a	42.1^a
Current indebtedness	36.4^a	440.6^a
Total current liabilities	1,044.2^a	1,586.3^a
Long-term debt, less current portion	3,581.7^a	3,632.8^a
Deferred income taxes	203.2^a	262.3^a
Other non-current liabilities	499.2^a	559.8^a
Total non-current liabilities	4,284.1^a	4,454.9^a
Total liabilities	5,328.3^a	6,041.2^a
Shareholders’ equity	—	—
Preferred shares	0^a	0^a
Ordinary shares	6,733.9^a	6,837.5^a
Accumulated other comprehensive income	-162.4^a	10.7^a
Retained earnings (accumulated deficit)	-2,252.1^a	-2,080.3^a
Total shareholders’ equity	4,319.4^a	4,767.9^a
Total liabilities and shareholders' equity	9,647.7^a	10,809.1^a

Download Data

Verified Sources Behind Perrigo’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Perrigo’s data sources below and access millions more through our Disclosure Search.

a. Perrigo's 10-K 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Perrigo Company PLC

Financial Statements of Perrigo

Verified Sources Behind Perrigo’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Sun Pharmaceutical Industries Ltd

Ipsen SA

Teva Pharmaceutical Industries Ltd

Bausch Health Companies Inc

Alkem Laboratories Ltd

Neurocrine Biosciences Inc